Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles.

  • Authors : Liu N; Cancer Institute of Xuzhou Medical University, Xuzhou, China.; Ji J

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Chemoradiotherapy*

  • Source: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2020 Dec; Vol. 48 (1), pp. 305-314.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101594777 Publication Model: Print Cited Medium: Internet ISSN: 2169-141X

Record details

×
Academic Journal

Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.

Subjects: Biomarkers, Tumor* ; Computational Biology*/Computational Biology*/Computational Biology*/methods ; Pharmacogenomic Testing*

  • Source: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2017 Dec 06; Vol. 20 (4), pp. 553-561.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101256509 Publication Model: Print Cited Medium: Internet ISSN: 1875-8592

Record details

×
Academic Journal

Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells.

  • Authors : Zhang X; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, Shanxi, China. .; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical Universtiy, Wenzhou, 325035, Zhejiang, China. .

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Antioxidants/Antioxidants/Antioxidants/*pharmacology ; Curcumin/Curcumin/Curcumin/*pharmacology

  • Source: BMC cancer [BMC Cancer] 2015 Nov 06; Vol. 15, pp. 866. Date of Electronic Publication: 2015 Nov 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells.

  • Authors : Eskew JD; The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, USA.; Sadikot T

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; HSP90 Heat-Shock Proteins/HSP90 Heat-Shock Proteins/HSP90 Heat-Shock Proteins/*antagonists & inhibitors ; Neoplasm Proteins/Neoplasm Proteins/Neoplasm Proteins/*antagonists & inhibitors

  • Source: BMC cancer [BMC Cancer] 2011 Oct 31; Vol. 11, pp. 468. Date of Electronic Publication: 2011 Oct 31.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence.

  • Authors : Liu C; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Photothermal Therapy*/Photothermal Therapy*/Photothermal Therapy*/methods ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 May 03; Vol. 22 (1), pp. 224. Date of Electronic Publication: 2024 May 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

×
Academic Journal

Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines.

  • Authors : Zhu L; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.; Liu B

Subjects: Drug Resistance, Neoplasm* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Quinazolinones*

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 21; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 21.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.

  • Authors : Zhao L; Department of Pathology and Genomic Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.; Wang Y

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 17; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

  • Authors : Chen N; Department of Urology, Meizhou People's Hospital, Meizhou 514089, China.; Wang Z

Subjects: Goserelin*/Goserelin*/Goserelin*/adverse effects ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy; Male

  • Source: Cancer biology & medicine [Cancer Biol Med] 2024 Feb 05; Vol. 20 (12).Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A New Synthesized Dicarboxylated Oxy-Heparin Efficiently Attenuates Tumor Growth and Metastasis.

  • Authors : Li L; Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen 518057, China.; Barash U

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy; Humans

  • Source: Cells [Cells] 2024 Jan 23; Vol. 13 (3). Date of Electronic Publication: 2024 Jan 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

×
Academic Journal

Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer.

  • Authors : Wang J; Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, 832000, Xinjiang, China.; Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, 832000, Xinjiang, China.

Subjects: Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Animals

  • Source: BMC cancer [BMC Cancer] 2024 Jan 15; Vol. 24 (1), pp. 75. Date of Electronic Publication: 2024 Jan 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
  • 1-10 of  340 results for ""Zhang X""